MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/jvh.70210

Медицинская библиотека · Journal of viral hepatitis · 2026

Trends in Mortality After the Roll-Out of Directly Acting Antivirals for Hepatitis C in England Using Linked Surveillance Data.

Etoori David, Simmons Ruth, Powell Annabel, Desai Monica, Trembling Paul, Sabin Caroline, Rosenberg William

СтатьяНаблюдательное исследованиеПеревод в очереди

Аннотация

Directly acting antivirals (DAAs) revolutionised hepatitis C virus (HCV) treatment, offering higher cure rates. We aimed to quantify life expectancy (LE) differences between treated and untreated individuals diagnosed with HCV and assess the contributions of age and causes of death to these differences. We used routine HCV surveillance data linked with UK mortality records. Individuals contributed person-time from age 15 or the earliest HCV diagnosis, whichever was later, and were classified as treated six months post-treatment initiation. The study was divided into two periods: 2015-2018 (Period 1), representing early DAA roll-out targeting advanced liver disease, and 2019-2022 (Period 2). We used non-parametric survival analysis methods and mortality decomposition methods to estimate LE differences, and age- and cause-specific contributions to LE differences. A total of 92,920 individuals contributed 322,570 untreated and 200,581 treated person-years of observation, and 13,294 deaths to the analyses. In Period 1, there was an 8.5-year LE advantage at age 15 for treated females (95% CI: 5.4-11.5) and 8.9 years for treated males (95% CI: 5.6-12.2). In Period 2, this declined to 6.7 (95% CI: 3.3-10.2) and 5.3 (95% CI: 3.0-7.6), respectively. The narrowing gap was driven by rising deaths from suicide, alcohol, and drug misuse in the treated population and corresponding declines in the untreated population. Treated individuals with HCV had consistently higher LE, though the advantage decreased over time. We hypothesise that the early prioritisation of individuals with cirrhosis resulted in a relatively healthier untreated population (i.e., fewer cirrhotic cases) in the later period.

Для цитирования: Etoori David, Simmons Ruth, Powell Annabel, Desai Monica, Trembling Paul, Sabin Caroline, Rosenberg William. Trends in Mortality After the Roll-Out of Directly Acting Antivirals for Hepatitis C in England Using Linked Surveillance Data.. Journal of viral hepatitis. 2026. DOI: 10.1111/jvh.70210.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.